The REVSIRIO brand, founded in 2011 (Japan), from 33 sister brands and 17477 competing brands. The REVSIRIO brand is owned by Santen Pharmaceutical, a company listed in Francfort. The International Securities Identification Number (ISIN) of Santen Pharmaceutical is JP3336000009. REVSIRIO is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Santen Pharmaceutical
(REVSIRIO)
over 5 years*
EUR 6.13